Annual Report 2003

Conseil d'examen du prix des médicaments brevetés - Patented Medicine Prices Review Board

> Annual Report 2003

Annual Report 2003

Annual Report (PDF)

Return to Annual Reports

Table Of Contents

1.	Press Release

2.	Highlights for 2003

3.	Letter To The Minister

4.	Chairperson's Message

5.	About The Patented Medicine Prices Review Board: Mandate and Jurisdiction

6.	Regulating Prices Of Patented Medicines

6.1.	Sales of Drugs in Canada

6.2.	Compliance And Excessive Price Guidelines

6.3.	Advance Ruling Certificate

6.4.	Voluntary Compliance Undertakings

6.5.	Quasi-Judicial Activities

7.	Reporting Information On Key Pharmaceutical Trends

7.1.	Trends In Manufacturers’ Sales Of Drugs In Canada And Other Countries

7.2.	The Global Context

7.3.	Trends In Drug Prices And Expenditures

7.4.	National Prescription Drug Utilization Information System

7.5.	Analysis Of Research-Anddevelopment Expenditure

8.	Policy and Research Initiatives

8.1.	Research Agenda

8.2.	Pilot Project For A Complaints-Driven Approach For The Regulation Of Patented Drug Prices For Veterinary Use: Next Steps

8.3.	Timelines Review Project

8.4.	Communications

9.	Governance

9.1.	Members of the Board and Senior Staff

9.2.

10.	Publications

11.

12.

13.

14.

15.

Annex 3

15.1.

15.2.

15.3.

16.	Patented Drug Products for Human Use and Canadian Patentees

17.

View Full Report


Last Updated: 2004-10-06		Important Notices